It makes sense to make in India and service other markets from here: Elie Chaillot, president & CEO, GE HealthCare
India as part of its supply chain diversification strategy. In an interview with Viswanath Pilla, Elie Chaillot, president & CEO of GE HealthCare International, called on India to simplify tax structure, give adequate reimbursement schemes and easy financing to spur expansion of the Indian healthcare market and attract more investments. Edited excerpts:
What makes you hedge your bets on India, which is a smaller market for your products?
We think of India as a market and this market is growing in double-digits every year; it's going to continue to grow. We also think of what India can offer in terms of qualified human resources, and competitiveness of 'Make in India'.
GE HealthCare is talking about supply chain resilience ever since the pandemic. How far have you reached, and what is the India role?
We are moving forward. We have announced we will export the India-made PET CT Discovery IQ medical imaging machine to 15 countries. Additionally, key CT scan products like Revolution Aspire CT and Revolution ACT will also be exported from India. We also localised MRI coils. There are other announcements coming. India has high demand. So, it makes sense to make it here and service other markets from here. We are shifting some manufacturing from other places, and we are also making in India from scratch.
What has really changed in India in the last several years, in ease of doing business?
If you look at what's happened in the last few years, now you have 100% foreign direct investment (FDI) in medical devices; there
